Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Demodex mites can cause skin issues, especially in people with weak immune systems.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Enhancing cannabinoid signaling may help treat skin inflammation.

FFA patients have fewer melanocytes and thinner skin compared to others.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Bullous pyoderma gangrenosum can develop on cesarean scars and may require steroids for treatment.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

PRP is an effective and safe treatment for alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Tph cells are linked to the severity of systemic lupus erythematosus.

New genetic discoveries may lead to better treatments for alopecia areata.